Older women who use statins may be at an increased risk for diabetes mellitus, according to the results of a study published online January 9, in the Archives of Internal Medicine.
Older women who use statins may be at an increased risk for diabetes mellitus (DM), according to the results of a study published online January 9 in the Archives of Internal Medicine.
The results of this study imply that statin use may increase risk of new-onset DM in postmenopausal women and that potency or individual statin may not play a role, according to lead study author Annie L. Culver, BPharm, Divisions of Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester, Mass., and colleagues.
The authors examined statin use among postmenopausal women participating in the Women's Health Initiative (WHI), which recruited 161,808 postmenopausal women aged 50 to 79 years at 40 US clinical centers between 1993 and 1998 with ongoing follow-up. The investigators used WHI data through 2005 for a total of 153,840 women who had not been diagnosed with DM and with no missing data at baseline.
A total of 7.04% of the patients reported taking a statin medication. Researchers found statin use at baseline was associated with an increased risk of DM (HR=1.71; 95% CI, 1.61–1.83), and the association remained consistent after adjusting for other potential confounders (HR=1.48; 95% CI, 1.38–1.59) and was observed for all types of statin medications.
“The consequences of statin-induced DM have not been specifically defined and deserve more attention,” the authors wrote. “Given the wide use of statins in the aging population, further studies among women, men, and diverse ethnicities will clarify DM risk and risk management to optimize therapy.”
Coalition promotes important acetaminophen dosing reminders
November 18th 2014It may come as a surprise that each year Americans catch approximately 1 billion colds, and the Centers for Disease Control and Prevention estimates that as many as 20% get the flu. This cold and flu season, 7 in 10 patients will reach for an over-the-counter (OTC) medicine to treat their coughs, stuffy noses, and sniffles. It’s an important time of the year to remind patients to double check their medicine labels so they don’t double up on medicines containing acetaminophen.
Support consumer access to specialty medications through value-based insurance design
June 30th 2014The driving force behind consumer cost-sharing provisions for specialty medications is the acquisition cost and not clinical value. This appears to be true for almost all public and private health plans, says a new report from researchers at the University of Michigan Center for Value-Based Insurance Design (V-BID Center) and the National Pharmaceutical Council (NPC).
Management of antipsychotic medication polypharmacy
June 13th 2013Within our healthcare-driven society, the increase in the identification and diagnosis of mental illnesses has led to a proportional increase in the prescribing of psychotropic medications. The prevalence of mental illnesses and subsequent treatment approaches may employ monotherapy as first-line treatment, but in many cases the use of combination of therapy can occur, leading to polypharmacy.1 Polypharmacy can be defined in several ways but it generally recognized as the use of multiple medications by one patient and the most common definition is the concurrent use of five more medications. The presence of polyharmacy has the potential to contribute to non-compliance, drug-drug interactions, medication errors, adverse events, or poor quality of life.
Medical innovation improves outcomes
June 12th 2013I have been diagnosed with stage 4 cancer of the pancreas, a disease that’s long been considered not just incurable, but almost impossible to treat-a recalcitrant disease that some practitioners feel has given oncology a bad name. I was told my life would be measured in weeks.